Lecture 16 (Exam 4 Local Anesthetics Part I) Flashcards
What was the first local anesthetic?
Cocaine
Cocaine is an ester.
What was cocaine first used for and what was the effect?
Ophthalmology (1884)
Local vasoconstriction: shrink nasal mucosa.
What was the first synthetic ester developed in 1905?
Procaine
What was the first synthetic amide developed in 1943?
Lidocaine
Gold Standard
What are the uses Local Anesthetics (LAs)?
- Treat dysrhythmias
- Analgesia: Acute and chronic pain
- Anesthesia- ANS Blockade, Sensory Anesthesia, Skeletal Muscle Paralysis
What antiarrhythmic Drug Class is lidocaine in?
Class I: Sodium Channel Blockers
MAGA: What is the intra-op infusion dose of lidocaine?
1 mg/kg over an hour
MAGA:
What is the IV dose of Lidocaine?
When should lidocaine be terminated?
- 1 to 2 mg/kg IV (initial bolus) over 2 - 4 min.
- 1 to 2 mg/kg/hour (drip)
- terminated 12 - 72 hours
What are considerations of lidocaine?
Careful monitoring: cardiac, hepatic, renal dysfunction
Dose Dependent Effects of Lidocaine if plasma lidocaine concentration is 1-5 mcg/ml.
Analgesia
Dose Dependent Effects of Lidocaine if plasma lidocaine concentration is 5-10 mcg/ml.
- Circum-oral numbness
- Tinnitus
- Skeletal muscle twitching
- Systemic hypotension
- Myocardial depression
Dose Dependent Effects of Lidocaine if plasma lidocaine concentration is 10-15 mcg/ml.
- Seizures
- Unconsciousness
Dose Dependent Effects of Lidocaine if plasma lidocaine concentration is 15-25 mcg/ml.
- Apnea
- Coma
Dose Dependent Effects of Lidocaine if plasma lidocaine concentration is >25 mcg/ml.
- Cardiovascular Depression
Describe the components that make up the molecular structure of lidocaine.
Lipophilic Portion (Aromatic Section)
Hydrocarbon Chain
Hydrophilic (Amino Group)
Bond between the lipophilic portion and the hydrocarbon chain will determine if LA is an ester or an amide.
Composition of LA will have a pH of _____ and are weak _______. ?
pH of 6; weak bases
A majority of LA are weak bases
Procaine
Classification:
Potency:
Onset:
Duration after infiltration (min):
Max single dose for infiltration (mg):
pK:
Protein Binding (%):
Procaine
Classification: Ester
Potency: 1
Onset: Slow
Duration after infiltration (min): 45-60
Max single dose for infiltration (mg): 500
pK: 8.9
Protein Binding (%): 6
Chloroprocaine
Classification:
Potency:
Onset:
Duration after infiltration (min):
Max single dose for infiltration:
pK:
Chloroprocaine
Classification: Ester
Potency: 4
Onset: Rapid
Duration after infiltration (min): 30-45
Max single dose for infiltration (mg): 600
pK: 8.7
Tetracaine
Classification:
Potency:
Onset:
Duration after infiltration (min):
Max single dose for infiltration:
pK:
Protein Binding (%):
Tetracaine
Classification: Ester
Potency: 16
Onset: Slow
Duration after infiltration (min): 60-180
Max single dose for infiltration (mg): 100 (topical)
pK: 8.5
Protein Binding (%): 76
Lidocaine
Classification:
Potency:
Onset:
Duration after infiltration (min):
Max single dose for infiltration:
Toxic Plasma Concentration (mcg/mL)
pK:
Protein Binding (%):
Lidocaine
Classification: Amide
Potency: 1
Onset: Rapid
Duration after infiltration (min): 60-120
Max single dose for infiltration (mg): 300
Toxic Plasma Concentration (mcg/mL): >5
pK: 7.9
Protein Binding (%): 70
Prilocaine
Classification:
Potency:
Onset:
Duration after infiltration (min):
Max single dose for infiltration:
Toxic Plasma Concentration (mcg/mL)
pK:
Protein Binding (%):
Prilocaine
Classification: Amide
Potency: 1
Onset: Slow
Duration after infiltration (min): 60-120
Max single dose for infiltration (mg): 400
Toxic Plasma Concentration (mcg/mL): >5
pK: 7.9
Protein Binding (%): 55
Mepivacaine
Classification:
Potency:
Onset:
Duration after infiltration (min):
Max single dose for infiltration:
Toxic Plasma Concentration (mcg/mL)
pK:
Protein Binding (%):
Mepivacaine
Classification: Amide
Potency: 1
Onset: Slow
Duration after infiltration (min): 90-180
Max single dose for infiltration (mg): 300
Toxic Plasma Concentration (mcg/mL): >5
pK: 7.6
Protein Binding (%): 77
Bupivacaine
Classification:
Potency:
Onset:
Duration after infiltration (min):
Max single dose for infiltration:
Toxic Plasma Concentration (mcg/mL)
pK:
Protein Binding (%):
Bupivacaine
Classification: Amide
Potency: 4
Onset: Slow
Duration after infiltration (min): 240-480
Max single dose for infiltration (mg): 175
Toxic Plasma Concentration (mcg/mL): >3
pK: 8.1
Protein Binding (%): 95
Levobupivacaine
Classification:
Potency:
Onset:
Duration after infiltration (min):
Max single dose for infiltration:
pK:
Protein Binding (%):
Levobupivacaine
Classification: Amide
Potency: 4
Onset: Slow
Duration after infiltration (min): 240-480
Max single dose for infiltration: 175
pK: 8.1
Protein Binding (%): >97